1. Home
  2. LION vs MIRM Comparison

LION vs MIRM Comparison

Compare LION & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LION
  • MIRM
  • Stock Information
  • Founded
  • LION 1997
  • MIRM 2018
  • Country
  • LION United States
  • MIRM United States
  • Employees
  • LION N/A
  • MIRM N/A
  • Industry
  • LION Movies/Entertainment
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LION Consumer Discretionary
  • MIRM Health Care
  • Exchange
  • LION Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • LION 1.6B
  • MIRM 2.5B
  • IPO Year
  • LION N/A
  • MIRM 2019
  • Fundamental
  • Price
  • LION $5.72
  • MIRM $52.66
  • Analyst Decision
  • LION Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • LION 6
  • MIRM 9
  • Target Price
  • LION $9.58
  • MIRM $66.22
  • AVG Volume (30 Days)
  • LION 2.1M
  • MIRM 456.2K
  • Earning Date
  • LION 08-07-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • LION N/A
  • MIRM N/A
  • EPS Growth
  • LION N/A
  • MIRM N/A
  • EPS
  • LION N/A
  • MIRM N/A
  • Revenue
  • LION $3,947,900,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • LION N/A
  • MIRM $35.83
  • Revenue Next Year
  • LION $7.02
  • MIRM $16.83
  • P/E Ratio
  • LION N/A
  • MIRM N/A
  • Revenue Growth
  • LION N/A
  • MIRM 69.31
  • 52 Week Low
  • LION $5.55
  • MIRM $36.17
  • 52 Week High
  • LION $8.50
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • LION 39.97
  • MIRM 64.66
  • Support Level
  • LION $5.55
  • MIRM $49.22
  • Resistance Level
  • LION $5.86
  • MIRM $53.86
  • Average True Range (ATR)
  • LION 0.19
  • MIRM 1.57
  • MACD
  • LION 0.02
  • MIRM 0.08
  • Stochastic Oscillator
  • LION 26.76
  • MIRM 79.63

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: